01 About Pars Capital

Elite Institutional Pedigree. Uncompromising Sector Focus.

Pars Capital Partners, LLC is a premier, pure-play independent investment banking advisory services firm dedicated exclusively to the global clinical trial infrastructure and pharmaceutical outsourcing markets. We bridge the gap between complex life-science operations and sophisticated institutional-grade corporate finance.

Explore Our Capabilities
02 Executive Pedigree & Regulatory DNA

Founded on Wall Street Rigor, Tailored for Life Sciences.

Our transactional DNA is anchored in our Managing Partner's historical FINRA and SEC broker registration, forged at world-class institutional broker-dealers including Morgan Stanley, Merrill Lynch Bank of America, and BrokerBank Securities.

In the clinical space, a single FDA or cGMP deviation can destroy years of drug development. We approach corporate finance with that exact same philosophy. We bring institutional data integrity, strict confidentiality, and regulatory precision to a middle market historically vulnerable to unvetted buyers and value-eroding leaks.

View Our Process

Rudy Sangari, Managing Partner
MANAGING PARTNER
Rudy Sangari
03 The Three Unshakable Pillars

The Pillars of the Pars Premium.

Pure-Play Sector Fluency

We eliminate the operational learning curve entirely. We understand capacity utilization, cleanroom classifications, therapeutic modalities, and clinical trial phase transitions out of the box.

Institutional Compliance & Regulatory Rigor

We bring a culture of compliance, absolute data protection, and strict fiduciary discipline to every transaction, acting as an institutional peer to global buyers.

Unrivaled Strategic & Financial Distribution

We enter every market mandate backed by over 1,400 established, proprietary relationships with life science executives and over 150 vetted, LifeScience focused financial sponsors.

Access Sub-Sector Analyses

04 Operational Scale & Reach

Quantifiable Market Distribution.

We do not rely on passive marketing or generic broker spreadsheets. Pars Capital has systematically mapped the clinical trial outsourcing landscape from the ground up. By matching an asset's precise scientific niche with a buyer's explicit strategic needs, we build highly competitive, controlled markets that maximize lifetime enterprise value.

Contact An Advisor

1,400+
Life Science & CDMO Executive Contacts
150+
Pharma-Mandated Financial Sponsors
05 Scientific Legacy

Protect Your Lifework and Scientific Legacy.

Independent founders face aggressive, non-vetted cold calls from predatory buyers looking for undervalued proprietary deals. We convert single, unvetted offers into structured, highly confidential multi-bid competitive auctions. Let us insulate your asset and ensure your scientific legacy is preserved post-transaction.

Schedule a Confidential Consultation